Stock Ticker

  • Loading stock data...

CarpX™ Of PAVmed Inc (NASDAQ:PAVMU) Receives Recognition As An Outstanding Innovation

The stock of PAVmed Inc (NASDAQ:PAVMU) closed at $14.50 gaining 5.45% in yesterday’s trading session. PAVmed takes great pride in the fact that CarpX™ got one of the top four slots awarded by the Technology Innovation category of the 2017 Fierce Innovation Awards. PAVmed’s Chairman and Chief Executive Officer, Lishan Aklog opined, “PAVmed is honored […]

Novavax, Inc. (NASDAQ:NVAX) Shares Fall On RSV, NanoFlu Vaccine Updates

At the star of this year, analysts predicted that investors in Novavax, Inc. (NASDAQ:NVAX) would be keenly watching for any update in December that could give any signal the future of Gaithersburg biotech. On the contraly, investors got a different announcement. The company’s shares went down by 22% on Tuesday. This was triggered by the […]

Sprint Corp (NYSE:S) Takes Top Honours In Chicagoland’s Internet Speed Tests

Speed tests conducted by independent testing and metrics firm, Ookla Speedtest, have revealed that Sprint Corp (NYSE:S) took the crown in 16 Chicagoland cities with regards to the fastest internet download speeds. Sprint recently completed a network upgrade in nine Chicagoland public venues. “…customers now have another reason to switch to Sprint. The Ookla wins […]

CVS Health Corp (NYSE:CVS) and Optum Expansion Triggers Hospital Consolidation

Only a week after CVS Health Corp (NYSE:CVS) announced it had acquired health insurer Aetna, a number of faith based not-for-profit hospital operators are consolidating to form regional health giants to ward off competition. With the expansion of CVS Health and Optum, which intend to acquire dozens of doctor clinics, low cost health providers and […]

Galectin Therapeutics Inc (NASDAQ:GALT) Reports Data From Phase 2b NASH-CX Study

Galectin Therapeutics Inc (NASDAQ:GALT) reported that its Phase 2b NASH-CX study of GR-MD-02 demonstrated statistically notable and clinically meaningful data in lowering the primary endpoint measurement of hepatic venous pressure gradient against placebo in NASH cirrhosis subjects without esophageal varices, which showcased 50% of the patients registered in the clinical study. The details Galectin noted […]

PhaseRx Inc (NASDAQ:PZRX) Updates On Orphan Drug Designation For PRX-ASL

PhaseRx Inc (NASDAQ:PZRX) reported that the European Medicines Agency’s COMP has given a positive view recommending orphan medicinal product status for PRX-ASL, for the cure of argininosuccinate lyase deficiency, the company’s second drug candidate to cure a urea cycle disorder. The details ASLD can be stated as a rare liver disorder, which is a result […]

How Egalet Corp (NASDAQ:EGLT) Fared In Q3 2017?

Egalet Corp (NASDAQ:EGLT) issued financial report for the third quarter closed September 30, 2017. As of September 30, 2017, the company recorded cash/cash equivalents and marketable securities of $102.1 million. Total net product sales came at $6.7 million for the quarter closed September 30, 2017 versus $4.7 million for the quarter closed September 30, 2016. […]

How Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) Fared In Q3 2017?

Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) issued financial report for the third quarter closed September 30, 2017. Revenue came at $1.6 million for Q3 2017, which comprises $0.3 million in industrial sales and $1.3 million in medical device revenue. This compared to revenue of $1.6 million for Q3 2016, which included $0.4 million in industrial sales […]

Dextera Surgical Inc (NASDAQ:DXTR) Anticipates To Start Shipping Reloads In December

Dextera Surgical Inc (NASDAQ:DXTR) issued financial report for its fiscal first quarter closed September 30, 2017. Julian Nikolchev, the CEO and President, expressed that they are achieving progress toward resolving their raw material and component supply challenges and anticipate to start shipping reloads in December and to addressing current backorder of $225,000 and going back […]

Why OncoSec Medical Inc (NASDAQ:ONCS) Is Making Noise?

OncoSec Medical Inc (NASDAQ:ONCS) presented emerging results from its unique, multi-gene expression platform named PIIM. The poster presentation was showcased during the “Oncolytic Viruses & Intratumoral Therapies” session on November 10 at the SITC Annual Meeting 2017. The details The PIIM platform establishes upon OncoSec’s current plasmid-based cancer immunotherapy base and may provide both manufacturing […]

How Community Health Systems (NYSE:CYH) Fared In The Third Quarter?

Community Health Systems (NYSE:CYH) issued operating and financial report for the quarter and nine-months closed September 30, 2017. Net operating revenues for quarter closed September 30, 2017 came at $3.666 billion, a 16.3% drop, as against with $4.380 billion for the comparable period in 2016. The details Commenting on the third quarter performance, Wayne T. […]

GenMark Diagnostics, Inc (NASDAQ:GNMK) Placed 65 ePlex® Analyzers In Q3 2017

GenMark Diagnostics, Inc (NASDAQ:GNMK) issued financial report for the third quarter closed September 30, 2017. During the reported quarter, the company placed 65 ePlex® analyzers, mostly led by first full quarter of U.S. release. The company recorded the total installed base of 147 ePlex analyzers in European and U.S. labs. The details Hany Massarany, the […]

Oclaro Inc (NASDAQ:OCLR) Q12018 Revenue Jumps 4% Sequentially

Oclaro Inc (NASDAQ:OCLR) reported its financial data for the first quarter of FY2018, which closed September 30, 2017. Greg Dougherty, the Chief Executive Officer, expressed that the Oclaro team once again recorded impressive quarterly results, supported by their QSFP and CFP2-ACO product lines. They recorded strong profitability and sequential revenue growth. Their near-term visibility comprises […]

Idera Pharmaceuticals Inc (NASDAQ:IDRA) Releases Corporate Governance Update

Idera Pharmaceuticals Inc (NASDAQ:IDRA) reported that Youssef El Zein has elected to step down from the firm’s Board, effective immediately. Mr. Zein has served as a member of company’s Board since 1992 and during that tenure has demonstrated remarkable energy, strategic influence and passion as well as playing a major role through Pillar’s financial support […]

Geron Corporation (NASDAQ:GERN) Reports Fast Track Designation For Imetelstat Targeting Lower Risk Myelodysplastic Syndromes

Geron Corporation (NASDAQ:GERN) reported that the U.S. FDA has granted Fast Track designation to imetelstat for the prospective treatment of adult people with transfusion-dependent anemia following low or Intermediate-1 risk MDS who are non-del and who are resistant or refractory to treatment with an ESA. Imetelstat marks as a telomerase inhibitor initially advanced by Geron […]

Sign Up To Get Our Latest Stocks Alerts